Article
Bluebird's $2.8 million gene therapy becomes most expensive drug after U.S. approval
Rating:
0.0
Views:
103
Likes:
1
Library:
1
The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare disorder requiring regular blood transfusions, and the drugmaker priced it at a record $2.8 million.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value